A Part 1 medical trial analyzing whether or not a topical cream can improve the immune response conferred by a ‘pre-pandemic’ influenza vaccine is underway. Investigators are evaluating whether or not imiquimod cream, generally used to deal with genital warts and sure pores and skin cancers, can increase the physique’s immune response to an H5N1 influenza vaccine. The trial is enrolling 50 wholesome adults ages 18-50 years.
- Lead poisoning might cut back gene expression in people
- US shale stays in survival mode for one more yr
- 'Cease making a large number!' Evgenia Medvedeva dismisses rumors she’s becoming a member of Evgeni Plushenko’s academy
- WATCH highly effective shockwave from Beirut explosion hit church as friends collect for wedding ceremony
- New York Abuses the Authorized System to Goal The NRA
